AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

AMZN

186.08

-1.64%↓

TSLA

171.09

-2.13%↓

HD

342.13

-1.62%↓

TM

242.86

-1.58%↓

MCD

267.25

-0.52%↓

HomeStock ListBoot Barn Holdings Inc

Boot Barn Holdings Inc

Closed

Sector Consumer cyclical

98.84 -2.9

Overview

Share price change

24h

Current

Min

96.64

Max

101.76

Recommendations

By TipRanks

Rating Consensus

StrongBuy

12 Months Forecast

-9.85 downside

Dividends

By Dow Jones

Next earnings

15 May 2024

News Sentiment

By Acuity

50%

50%

95 / 239 Ranking in Consumer cyclical

Technical Score

By Trading Central

Confidence

Bullish Evidence

Boot Barn Holdings Inc chart

Related News

10 Apr 2024, 22:48 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Vera Therapeutics Shares Rise 9.9% After Alpine Acquisition

10 Apr 2024, 21:40 UTC

Major Market Movers
Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences Shares Rally After Vertex Agrees to Acquire Co.

10 Apr 2024, 21:24 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 20:30 UTC

Top News
Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

10 Apr 2024, 23:06 UTC

Market Talk
Earnings

Investors Await Macquarie's FY 2025 Guidance -- Market Talk

10 Apr 2024, 22:57 UTC

Market Talk

Aussie Banks Unlikely to Get Upgrades Out of Earnings Season -- Market Talk

10 Apr 2024, 21:47 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9 Billion -- Update

10 Apr 2024, 21:35 UTC

Top News

Buy the Stock Market's Inflation Freakouts -- Heard on the Street -- Update

10 Apr 2024, 21:09 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B -- Update

10 Apr 2024, 21:05 UTC

Market Talk

Mexican Stocks Close Lower; Peso Weakens Against Dollar -- Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 Apr 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 Apr 2024, 20:46 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal -- IBD

10 Apr 2024, 20:28 UTC

Market Talk

Only CPI Surprise, Big-Spending Budget Can Derail Canada Rate Cut in June -- Market Talk

10 Apr 2024, 20:27 UTC

Top News

Hot Inflation Report Weakens Case for Fed's June Rate Cut -- 8th Update

10 Apr 2024, 20:15 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences for $4.9B

10 Apr 2024, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

10 Apr 2024, 20:08 UTC

Market Talk

SPDR Gold Drops Following Inflation Data -- Market Talk

10 Apr 2024, 20:04 UTC

Acquisitions, Mergers, TakeOvers

Alpine Immune Sciences: Vertex Will Acquire Alpine for $65 Per Shr or Approximately $4.9B in Cash, Transaction Approved by Both Boards of Directors, Anticipated to Close in 2Q >ALPN

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex Subsidiary Will Commence Cash Tender Offer to Purchase All Alpine Common Stk >VRTX

10 Apr 2024, 20:03 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Alpine Is Strategic Fit and Furthers Use of Scientific Innovation to Create Transformative Medicines Targeting Serious Diseases With High Unmet Need in Specialty Markets >VRTX

10 Apr 2024, 20:02 UTC

Acquisitions, Mergers, TakeOvers

Vertex: Transaction Was Unanimously Approved by Both the Vertex and Alpine Boards

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Pharmaceuticals Will Acquire Alpine for $65 Per Shr or About $4.9 B in Cash >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 20:01 UTC

Acquisitions, Mergers, TakeOvers

Vertex Enters Into Agreement To Acquire Alpine Immune Sciences >VRTX ALPN

10 Apr 2024, 19:58 UTC

Market Talk

Markets Largely Ignored BOC's Macklem's Remark on Possible June Cut -- Market Talk

10 Apr 2024, 19:10 UTC

Market Talk

U.S. Natural Gas Futures Eke Out Gains Ahead of Storage Report -- Market Talk

Peer Comparison

Price change

Boot Barn Holdings Inc forecast

Price Target

By TipRanks

-9.85% downside

12 Months Forecast

Average 90.92 USD  -9.85%

High 115 USD

Low 80 USD

Based on 13 Wall Street analysts offering 12 month price targets for Boot Barn Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

StrongBuy

13 ratings

10

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

93 / N/A Support&Resistance

Short Team

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

95 / 239 Ranking in Consumer cyclical

News Sentiment

Neutral

Volatility

Below average

News volume (RCV)

Below average